GlaxoSmithKline (GSK)

NYSE:GSK

US Market

GSK

GlaxoSmithKline

RESEARCH TOOLSreports

Want to see GSK full AI Analyst Report?

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

5,227 Followers

GlaxoSmithKline (GSK) Ownership Overview

6.65% Mutual Funds

0.72% Other Institutional Investors

0.37% ETFs

92.26% Public Companies and Individual Investors

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 7.74% of the company’s stock is owned by Institutional Investors, and 92.26% is owned by Public Companies and Individual Investors.

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, 6.65% is owned by Insiders, and 92.26% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Causeway Capital Management Llc	xxxxxxxxxxxxx	$1662309
Dec 31, 2023	Dodge & Cox	xxxxxxxxxxxxx	$3360121200
Dec 31, 2023	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$69466386
Dec 31, 2023	Auxier Asset Management	xxxxxxxxxxxxx	$1350169

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
John A. Gunn	68,517,969	Institution	3.38%	3,521,823,607
	55,475,472	Institution	2.74%	2,851,439,261
Ken Fisher	33,195,985	Institution	1.64%	1,706,273,629
Theofanis Kolokotrones	25,130,160	Institution	1.24%	1,291,690,224
	18,142,650	Institution	0.89%	932,532,210
	9,185,065	Institution	0.45%	472,112,341
	7,943,164	Institution	0.39%	408,278,630
	5,702,194	Institution	0.28%	293,092,772
	4,447,100	Institution	0.22%	228,580,940
George Davis Jr	3,657,931	Institution	0.18%	188,017,653

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	55,475,472	Institution	2.74%	2,851,439,261
	18,142,650	Institution	0.89%	932,532,210
	9,185,065	Institution	0.45%	472,112,341
	7,943,164	Institution	0.39%	408,278,630
	5,702,194	Institution	0.28%	293,092,772
	4,447,100	Institution	0.22%	228,580,940
	3,544,080	Institution	0.17%	182,165,712
	3,487,775	Institution	0.17%	179,271,635
	3,053,917	Institution	0.15%	156,971,334
	2,734,200	Institution	0.13%	140,537,880

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Avantis International Equity ETF	1,234,223	Institution	0.06%	67,228,127
Fidelity Enhanced International ETF	965,575	Institution	0.05%	52,594,870
VanEck Pharmaceutical ETF	819,645	Institution	0.04%	44,646,063
Fidelity Tactical High Income Fund Trust Units	680,400	Institution	0.03%	47,805,680
First Trust Value Line Dividend Index Fund	605,284	Institution	0.03%	31,111,598
Avantis International Large Cap Value ETF	270,836	Institution	0.01%	14,752,437
GMO International Value ETF	255,077	Institution	0.01%	13,894,044
Hartford Multifactor Developed Markets (ex-US) ETF	245,479	Institution	0.01%	13,371,241
AQE Core ETF	213,126	Institution	0.01%	11,608,973
Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged	199,456	Institution	<0.01%	14,869,518

FAQ

Who Owns GlaxoSmithKline (GSK)?

Currently, no data Available

What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.72% of GlaxoSmithKline (GSK) stock is held by institutional investors.

What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?

According to the latest TipRanks data, approximately 92.26% of GlaxoSmithKline (GSK) stock is held by retail investors.

Who owns the most shares of GlaxoSmithKline (GSK)?

John A. Gunn owns the most shares of GlaxoSmithKline (GSK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.